{
  "main_header": {
    "sid": 1116836,
    "name": "Guizhou Xinbang Pharmaceutical Co., Ltd.",
    "stock_name": "Guizhou Xinbang Pharmaceutical Co., Ltd.",
    "full_name": "Guizhou Xinbang Pharmaceutical Co., Ltd.",
    "name_url": "stocks-analysis/guizhou-xinbang-pharmaceutical-co-",
    "exchange": 46,
    "exchangecode": "SHE",
    "country_id": 12,
    "currency": "CNY",
    "cmp": "3.94",
    "chg": 0.1,
    "chgp": "2.6%",
    "dir": 1,
    "prev_price": "3.84",
    "mcapval": "6,314.34",
    "mcap": "Mid Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "China Shanghai Composite",
    "isin": "CNE100000NG5",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "104.56 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/guizhou-xinbang-pharmaceutical-co--1116836-46&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Flat Financial Performance with Notable Profit Growth",
        "link": "https://www.marketsmojo.com/news/mojo-premium/guizhou-xinbang-pharmaceutical-co-ltd-enters-hidden-turnarounds-strategy-due-to-strong-profit-growth-3526088",
        "imagepath": "",
        "date": "2025-09-17 17:14:47",
        "description": "<p><strong>Guizhou Xinbang Pharmaceutical Co., Ltd.</strong>, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has recently released its financial results for the quarter ending March 2025. The company has reported a flat financial performance during this period, indicating stability amidst a challenging market environment.</p>\n\n<p>One of the key highlights from the financial report is the significant growth in net profit, which reached CNY 41.24 MM, marking an impressive increase of 62.73% compared to the previous year. This growth in profitability suggests that <strong>Guizhou Xinbang Pharmaceutical Co., Ltd.</strong> is effectively managing its operations and capitalizing on market opportunities.</p>\n\n<p>Additionally, the company has experienced a decrease in raw material costs, which fell by 2.73% year-over-year. This reduction in costs could potentially enhance the company's margins and ..."
      }
    ],
    "total": 1,
    "sid": "1116836",
    "stock_news_url": "https://www.marketsmojo.com/news/guizhou-xinbang-pharmaceutical-co--1116836"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Flat Financial Performance with Notable Profit Growth

2025-09-17 17:14:47

Guizhou Xinbang Pharmaceutical Co., Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has recently released its financial results for the quarter ending March 2025. The company has reported a flat financial performance during this period, indicating stability amidst a challenging market environment.

One of the key highlights from the financial report is the significant growth in net profit, which reached CNY 41.24 MM, marking an impressive increase of 62.73% compared to the previous year. This growth in profitability suggests that Guizhou Xinbang Pharmaceutical Co., Ltd. is effectively managing its operations and capitalizing on market opportunities.

Additionally, the company has experienced a decrease in raw material costs, which fell by 2.73% year-over-year. This reduction in costs could potentially enhance the company's margins and ...

Read More

View All News